Remove 2009 Remove Clinical Trials Remove Collective Remove Sleep
article thumbnail

The history and science of psychedelics: from acid and shrooms to ketamine and salvia

The Cannigma

It became illegal in the US in 2009. Clinical research: Research is focusing on 5-MeO-DMT use in depression and anxiety. Current clinical trials are underway using a synthetic nasal spray of 5-MeO-DMT in patients with major depressive disorder. As such, there have been numerous clinical trials using ketamine.

History 119
article thumbnail

A Hidden Origin Story of the CBD Craze

SMPL

And though a few outliers responded well to CBD alone, GW’s data showed that for relieving pain and inflammation, helping with sleep and alleviating seizures and spasms, most patients got the most benefit from an equal mix of CBD and THC — a drug the company called Sativex. But the research wasn’t enough.

CBD 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Data collection. Less frequent were references to multiple sclerosis, anxiety and depression, sleep, and HIV. It is unclear whether doctors are feeling completely reassured by laboratory and clinical trial research into medicinal cannabis. New York: Routledge; 2009. Conditions most frequently mentioned. 1995:920–3.

article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Originally a lawyer, Yang began working in startups and early stage growth companies as a founder or executive from 2000 to 2009.